Real-world clinical outcomes in patients with biochemical recurrence after local therapy for non-metastatic prostate cancer
Summary
PSA and PSA-DT are key predictors of BCR. Outcomes are worse among high-risk BCR patients with short PSA-DT.
Description
PSA and PSA-DT are key predictors of BCR. Outcomes are worse among high-risk BCR patients with short PSA-DT.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source